Aura Biosciences (AURA) Cash from Operations (2020 - 2026)
Aura Biosciences (AURA) posted Cash from Operations of 29893000.0 for Q1 2026, down 46.34% on a QoQ basis from 20427000.0 in Q4 2025, and down 27.99% year-over-year from 41514599.22 in Q1 2025.
Aura Biosciences (AURA) Cash from Operations (2020 - 2026) Analysis & Trends
Aura Biosciences' Cash from Operations history runs 7 years deep, the most recent figure standing at 29893000.0 for Q1 2026.
- Quarterly Cash from Operations fell 27.99% year-over-year to 29893000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 91238000.0 (down 15.92% YoY) and the FY2025 annual result came in at 84700000.0, down 6.13% from the prior year.
- Cash from Operations was 29893000.0 for Q1 2026 at Aura Biosciences, down from 20427000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 10628000.0 in Q2 2022 and bottomed at 29893000.0 in Q1 2026.
- A 5-year average of 18402705.88 and a median of 17387000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations slumped 195.89% — and 2025, when it rose 14.72%.
- Aura Biosciences' Cash from Operations stood at 18013000.0 in 2022, then gained by 3.48% to 17387000.0 in 2023, then plunged by 37.76% to 23952000.0 in 2024, then advanced by 14.72% to 20427000.0 in 2025, then slumped by 46.34% to 29893000.0 in 2026.
- Business Quant data shows AURA's Cash from Operations at 29893000.0 in Q1 2026, 20427000.0 in Q4 2025, and 20144000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - | -29.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.89 Mn |
| Mar 31, 2026 | -29.89 Mn |
| Dec 31, 2025 | -20.43 Mn |
| Dec 31, 2025 | -20.43 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Jun 30, 2025 | -20.77 Mn |
| Jun 30, 2025 | -20.77 Mn |
| Mar 31, 2025 | -23.36 Mn |
| Mar 31, 2025 | -23.36 Mn |
| Dec 31, 2024 | -23.95 Mn |
| Dec 31, 2024 | -23.95 Mn |
| Sep 30, 2024 | -15.27 Mn |
| Sep 30, 2024 | -15.27 Mn |
| Jun 30, 2024 | -16.13 Mn |
| Jun 30, 2024 | -16.13 Mn |
| Mar 31, 2024 | -24.45 Mn |
| Mar 31, 2024 | -24.45 Mn |
| Dec 31, 2023 | -17.39 Mn |
| Dec 31, 2023 | -17.39 Mn |